Adam Singer is a Ph.D. candidate at the Pardee RAND Graduate School. He is pursuing an M.D. at the University of California, Los Angeles, School of Medicine while enrolled at PRGS as part of the National Institutes of Health Medical Scientist Training Program, a combined M.D./Ph.D. program. He has a B.A. in molecular and cell biology from the University of California, Berkeley. He has conducted molecular biological laboratory research on leukemia treatment and early-stage drug development for lowering LDL cholesterol. His interests include health policy, food policy, and quality improvement.